|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Digoxin immune fab#Pharmacology]] |
| {{Digoxin immune fab}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| '''''For patient information about Digoxin immune fab, click [[Digoxin immune fab (patient information)|here]].'''''
| |
| | |
| ==DESCRIPTION==
| |
| | |
| DigiFab® [Digoxin Immune Fab (Ovine)] is a sterile, purified, lyophilized preparation of digoxin-immune ovine Fab (monovalent) immunoglobulin fragments. These fragments are obtained from the blood of healthy sheep immunized with a digoxin derivative, digoxin-dicarboxymethoxylamine (DDMA), a digoxin analogue which contains the functionally essential cyclopentaperhydrophenanthrene:lactone ring moiety coupled to keyhole limpet hemocyanin (KLH).
| |
| | |
| The final product is prepared by isolating the immunoglobulin fraction of the ovine serum, digesting it with papain and isolating the digoxin-specific Fab fragments by affinity chromatography. These antibody fragments have a molecular weight of approximately 46,000 Da.
| |
| | |
| Each vial of DigiFab, which will bind approximately 0.5 mg digoxin, contains 40 mg of digoxin immune Fab, 75 mg (approx) of mannitol USP, and 2 mg (approx) sodium acetate USP as a buffering agent.
| |
| | |
| The product contains no preservatives and is intended for intravenous administration after reconstitution with 4 mL of Sterile Water for Injection USP.
| |
| | |
| ==Mechanism of Action==
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6832767f-db6b-4eea-b88b-bdfc905749e1
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |